Nevro bucks trend with upsized IPO
This article was originally published in Clinica
Nevro has upsized its initial public offering, raising $126m from the sale of seven million shares at $18 each. The firm, which has a CE-marked spinal cord stimulation system for managing chronic pain, will begin trading on the New York Stock Exchange today, under the ticker symbol NVRO. The offering is expected to close 12 November.